BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Earnings
IRIDEX Corporation (IRIX) Reports 2014 Fourth Quarter, Year-End Results 3/6/2015
Centene Corporation Schedules 2015 First Quarter Financial Results Conference Call 3/6/2015
WuXi PharmaTech Co., Ltd. Announces Fourth-Quarter and Full-Year 2014 Results 3/6/2015
Pfenex (PFNX) To Report Fourth Quarter And Full Year 2014 Results And Provide Business Update 3/6/2015
BioLife Solutions, Inc. (BLFS.OB) To Report Fourth Quarter And Full Year 2014 Financial Results And Provide Business Update On March 12, 2015 3/6/2015
BioSpecifics Technologies Corporation (BSTC) To Host Conference Call To Report Fourth Quarter And Full Year 2014 Financial Results On Friday, March 13, 2015 3/6/2015
Par Pharmaceutical, Inc. Announces Fourth-Quarter And Full-Year 2014 Conference Call 3/6/2015
Peregrine Pharmaceuticals, Inc. (PPHM) To Report Third Quarter Fiscal 2015 Financial Results After Market On March 12, 2015 3/6/2015
Fate Therapeutics (FATE) To Webcast Conference Call Reporting Fourth Quarter And Full Year 2014 Financial Results On March 12, 2015 3/6/2015
Vital Therapies, Inc. (VTI) (VTL) Announces Fourth Quarter And Full Year 2014 Financial Results Conference Call With Webcast 3/6/2015
TetraPhase Pharmaceuticals (TTPH) Reports Fourth-Quarter And Full-Year 2014 Financial Results 3/6/2015
Retrophin (RTRX) Reports Fourth Quarter And Full Year 2014 Financial Results 3/6/2015
Anacor Pharmaceuticals, Inc. (ANAC) Announces 2014 Fourth Quarter And Year-End Financial Results Conference Call And Webcast 3/6/2015
Fibrocell Science, Inc. To Report Fourth Quarter 2014 And Full Year 2014 Financial And Operating Results, And Host Conference Call And Webcast On March 13, 2015 3/6/2015
AVEO Oncology (AVEO) Reports Full Year 2014 Financial Results 3/6/2015
Prothena Reports Fourth Quarter And Full Year 2014 Financial Results And Provides 2015 Financial Guidance And R&D Update 3/6/2015
Galena Biopharma  (GALE) Reports Fourth Quarter And Year End 2014 Financial Results 3/6/2015
Tekmira (TKMR) Conference Call And Webcast Advisory: Corporate Update And Full Year 2014 Financial Results 3/6/2015
Chimerix (CMRX) Announces Fourth Quarter And Full Year 2014 Financial Results 3/6/2015
Inovio Pharmaceuticals (INO) To Report Fourth Quarter And Year End 2014 Financial Results On March 16, 2015 3/6/2015
Cellular Dynamics Reports Fourth Quarter And Fiscal Year 2014 Financial Results 3/6/2015
AxoGen, Inc. (AXGN) Reports 61% Revenue Growth For The 2014 Fourth Quarter 3/6/2015
Galapagos NV (GLPG.BR) Reports 2014 Financial Results 3/6/2015
Oxford BioMedica PLC (OXB.L): Notice of Preliminary Results 3/6/2015
Esperion Therapeutics, Inc. (ESPR) Provides ETC-1002 Development Program Update; Reports Fourth Quarter And Full Year 2014 Financial Results 3/6/2015
Flamel Technologies (FLML) To Report Fourth Quarter Of Fiscal Year 2014 Results 3/6/2015
Dynavax Technologies Corporation (DVAX) Reports Fourth Quarter And Year End 2014 Financial Results 3/5/2015
Alder Biopharmaceuticals Inc. Reports Fourth Quarter And Year-End 2014 Financial And Operating Results 3/5/2015
Evoke Pharma, Inc. Reports Fourth Quarter And Year End 2014 Results 3/5/2015
OXiGENE (OXGN) Announces 2014 Financial Results Conference Call And Webcast 3/5/2015
Achillion (ACHN) Reports 2014 Fourth Quarter And Year-End Financial Results 3/5/2015
Avalanche Biotechnologies (AAVL) Reports Fourth Quarter And Fiscal 2014 Financial Results 3/5/2015
BioReference Laboratories, Inc. (BRLI) Reports Over 15% Increase In Revenue; Net Income Up Over 100%, Year Over Year 3/5/2015
Sunesis Pharmaceuticals, Inc. (SNSS) To Host Conference Call On March 12th To Discuss Fourth Quarter And Full-Year 2014 Financial Results And Recent Highlights 3/5/2015
Nevro Corp To Report Operating Results For The Fourth Quarter And Full Year Of 2014 3/5/2015
Sequenom Inc. (SQNM) Reports 2014 Final And Fourth Quarter Financials 3/5/2015
Alimera Sciences (ALIM) Reports Fourth Quarter And Full Year 2014 Financial Results 3/5/2015
Amgen (AMGN) Announces 2015 Second Quarter Dividend 3/5/2015
China Biologic Products Reports Financial Results For The Fourth Quarter And Fiscal Year 2014 3/5/2015
Siegfried Release: Annual Report 2014 3/5/2015
Celsion Corporation (CLSN) To Hold Year-End 2014 Financial Results Conference Call On Thursday, March 12, 2015 3/5/2015
Cellectis (ALCLS): 2014 Financial Results 3/5/2015
Antares Pharma, Inc. (ATRS) To Host Fourth Quarter 2014 Operating And Financial Results Conference Call 3/5/2015
Epizyme (EPZM) To Report Fourth Quarter 2014 Financial Results And Provide Corporate Update On March 12, 2015 3/5/2015
Osiris Therapeutics, Inc. (OSIR) Reports Fourth Quarter And Full Year 2014 Financial Results: For The Full Year, Revenue Increased 146% And Company Reports Record Revenue In Fourth Quarter 3/5/2015
CLARIFICATION Of Navidea Biopharmaceuticals (NAVB) Announces Fourth Quarter And Full Year 2014 Results 3/5/2015
Trimel Pharmaceuticals (TRL.TO) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 3/5/2015
2014: A Year Of Technical Achievements And Organizational Structure, Accelerating Carbios' Pre-Industrial Development 3/5/2015
Cardiome Pharma Corp. (COM.TO) To Hold Fourth Quarter And Full Year 2014 Financial Results Conference Call On March 12 3/5/2015
Corcept Therapeutics Inc. (CORT) Announces 2014 Financial Results And Provides Clinical Update 3/5/2015
Cryo-Cell International (CCEL) Reports Financial Results For Fiscal 2014 3/4/2015
Amicus Therapeutics, Inc. (FOLD) Announces Full-Year 2014 Financial Results And Corporate Updates 3/4/2015
Receptos (RCPT) Provides Development Updates And Reports Fourth Quarter And Year End 2014 Financial Results 3/4/2015
Adamas Pharmaceuticals (ADMS) Reports Fiscal 2014 Financial Results 3/4/2015
MacroGenics, Inc. (MGNX) Provides Update On Corporate Progress And 2014 Financial Results 3/4/2015
Codexis, Inc. (CDXS) Reports 2014 Fourth Quarter And Full Year Results 3/4/2015
Aptose Biosciences Reports Results For The Quarter And Seven Months Ended December 31, 2014 3/4/2015
VWR Corporation Reports Strong Fourth Quarter And Full Year 2014 Financial Results 3/4/2015
IMRIS Reports Fourth Quarter And Annual 2014 Financial Results 3/4/2015
Conatus Pharmaceuticals Inc. To Report Fourth Quarter And Full Year 2014 Financial Results 3/4/2015
Sucampo Pharmaceuticals, Inc. (SCMP) Reports Fourth Quarter And Full Year 2014 Financial Results And Corporate Update 3/4/2015
AcelRx Pharmaceuticals (ACRX) To Hold Annual 2014 Financial Results Conference Call And Webcast On Monday, March 9th, 2015 3/4/2015
Imprimis Pharmaceuticals (immy) To Host Its Fourth Quarter And Fiscal Year 2014 Financial Report Conference Call And Webcast On March 12, 2015 At 4:30 P.M. EDT 3/4/2015
Webcast Alert: Heska Corporation (HSKA) Announces Fourth Quarter And Year End 2014 Earnings Conference Call Webcast 3/4/2015
Geron Corporation (GERN) Reports Fourth Quarter And Annual 2014 Financial Results And Recent Events 3/4/2015
Veeva Systems, Inc. Announces Fourth Quarter And Fiscal Year 2015 Results 3/4/2015
Ocular Therapeutix, Inc. (OCUL) To Report Fourth Quarter And Full Year 2014 Financial Results 3/4/2015
GTx, Inc. (GTXI) Provides Corporate Update And Reports Fourth Quarter And Year-End 2014 Financial Results 3/4/2015
ArQule, Inc. (ARQL) Reports Fiscal 2014 Year End And Fourth Quarter Results 3/4/2015
Theravance Biopharma To Report Fourth Quarter 2014 Financial Results On March 10, 2015 3/4/2015
Akebia Therapeutics, Inc. (AKBA) Announces Fourth Quarter And Full-Year 2014 Financial Results 3/4/2015
Eleven Biotherapeutics (EBIO) Reports Fourth Quarter And Year-End 2014 Financial Results 3/4/2015
Derma Sciences, Inc. (DSCI) To Hold Fourth Quarter Financial Results Conference Call On March 12th 3/4/2015
Bellicum (BLCM) To Report Fourth Quarter And Full Year 2014 Financial Results On March 11, 2015 3/4/2015
Cytori Therapeutics, Inc. (CYTX) Provides Business Update Along With Top-Line Unaudited 2014 Financial Results At The Cowen and Company 35th Annual Health Care Conference In Boston 3/4/2015
Newron Pharmaceuticals (NWRN) Reports 2014 Financial Results 3/4/2015
Veeva Systems, Inc. Announces Fourth Quarter And Fiscal Year 2015 Results 3/4/2015
IGI Laboratories, Inc. Announces Fourth Quarter And Year End 2014 Results 3/3/2015
Clinigen Group Plc Release: Half Year Revenues Up 17% To £72.6m, Underlying EBITDA Up 8% To £13.5m 3/3/2015
DURECT Corporation (DRRX) Announces Fourth Quarter 2014 Financial Results And Update Of Programs 3/3/2015
TONIX Pharmaceuticals, Inc. (TNXP) Reports Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
NeoStem, Inc. Announces 2014 Year-End Financial Results And Provides Corporate Update 3/3/2015
Intrexon Corporation Announces Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
Ocera Therapeutics, Inc. (OCRX) To Announce Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
ReVance Therapeutics, Inc. (RVNC) Releases Fourth Quarter And Full Year 2014 Financial Results And Reiterates 2015 Outlook 3/3/2015
Mylan Inc. (MYL) Fourth Quarter 2014 Adjusted Diluted EPS Increases 35% To $1.05 And Full Year Adjusted Diluted EPS Up 23% To $3.56 3/3/2015
Zogenix, Inc. (ZGNX) Announces Conference Call And Webcast To Present Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
Oncothyreon Inc. (ONTY) Announces Full Year And Fourth Quarter 2014 Financial Results Conference Call 3/3/2015
Kindred Bio (KIN) To Announce Fourth Quarter And Year-End 2014 Financial Results 3/3/2015
OncoMed Pharmaceuticals, Inc. (OMED) To Report Full Year And Fourth Quarter 2014 Financial Results On Thursday, March 12, 2015 3/3/2015
KYTHERA Biopharmaceuticals, Inc. (KYTH) Announces 2014 Operating Results 3/3/2015
Halozyme Therapeutics, Inc. (HALO) Reports Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
Rigel (RIGL) Announces Fourth Quarter And Year End 2014 Financial Results 3/3/2015
INSYS Therapeutics Reports Fourth Quarter And Year End 2014 Results 3/3/2015
Threshold Pharmaceuticals, Inc. (THLD) Reports Fourth Quarter And Year End 2014 Financial And Operational Results 3/3/2015
Puma Biotechnology (PBYI) Reports Fourth Quarter And Full Year 2014 Financial Results 3/3/2015
Ipsen (IPN.PA)’s 2014 Results and 2015 Financial Objectives 3/3/2015
Clinigen Group Plc: Half Year Revenues Up 17% To £72.6m, Underlying EBITDA Up 8% To £13.5m 3/3/2015
Chimerix (CMRX) To Announce Fourth Quarter And Year End 2014 Financial Results On March 6, 2015 3/2/2015
Intercept Pharmaceuticals (ICPT) Announces 2014 Financial Results 3/2/2015
Portola Pharmaceuticals, Inc. Reports Fourth Quarter And Year-End 2014 Financial Results And Provides Corporate Update 3/2/2015
Second Quarter Results - Fiscal 2015 - Ergoresearch Inc. (ERG) Reports Its Results For The Quarter Ended December 31, 2014 3/2/2015
Asterias BiotherapeuticsTo Report Fourth Quarter And Full Year 2014 Results On March 10, 2015 3/2/2015
BioScrip (BIOS) Reports Fourth Quarter 2014 Financial Results 3/2/2015
Endo International (ENDP) Reports Fourth Quarter And Full Year 2014 Financial Results 3/2/2015
Lexicon Pharmaceuticals, Inc. (LXRX) To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 3/2/2015
Endocyte, Inc. (ECYT) Reports Fourth Quarter And Year End 2014 Financial Results And Provides Clinical Updat 3/2/2015
ImmunoCellular Therapeutics, Ltd (IMUC) To Report 2014 Financial Results On March 9, 2015; A Business Update Conference Call And Webcast Is Scheduled For March 12, 2015 3/2/2015
Allergy Therapeutics plc Release: Interim Report For The Six Months Ended 31 December 2014 3/2/2015
Acceleron Pharma Reports Fourth Quarter And Year Ended 2014 Financial And Operational Results 3/2/2015
BIND Therapeutics (BIND) To Report Fourth Quarter And Year-End 2014 Financial Results On March 11, 2015 3/2/2015
PharMerica Reports Fourth Quarter And Full Year 2014 Results 3/2/2015
Getinge Annual Report 2014 3/2/2015
Antibe Therapeutics Inc. (ATE.V) Reports Q3 2015 Interim Financial And Operating Results And Director Resignation 3/2/2015
Horizon Pharma plc.  (HZNP) Announces Fourth Quarter And Full Year 2014 Financial Results And Raises Guidance For 2015 3/2/2015
ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 3/2/2015
Synageva BioPharma (GEVA) Reports 2014 Full Year Financial Results 2/27/2015
IRIDEX Corporation (IRIX) Announces Fourth Quarter And Full Year 2014 Conference Call And Release Date 2/27/2015
Rockwell Medical (RMTI) Reports Fourth Quarter 2014 Results 2/27/2015
Raptor Pharmaceutical Inc. (RPTP) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides 2015 Corporate Update 2/27/2015
Hyperion Therapeutics (HPTX) Announces Fourth Quarter And Full Year 2014 Financial Results 2/27/2015
TetraPhase Pharmaceuticals (TTPH) To Host Conference Call Discussing Fourth Quarter And Full-Year 2014 Financial Results And Recent Highlights 2/27/2015
BioScrip (BIOS) To Host Fourth Quarter And Year-End 2014 Earnings Call 2/27/2015
Inogen (INGN) To Announce Fourth Quarter And Full Year 2014 Results On Thursday, March 12, 2015 2/27/2015
Novavax, Inc. (NVAX) Reports Fourth Quarter And Year-End 2014 Financial Results 2/27/2015
ZIOPHARM Oncology, Inc. (ZIOP.OB) Reports Fourth-Quarter And Full-Year 2014 Financial Results And Recent Activities 2/27/2015
SAGE Therapeutics Reports Fourth Quarter And Full Year 2014 Financial Results 2/27/2015
Keryx Biopharmaceuticals (KERX) Announces Fourth Quarter And Year-End 2014 Financial Results 2/27/2015
TetraLogic Pharmaceuticals (TLOG) Reports 2014 Financial Results And Provides Clinical Programs Update 2/27/2015
Esperion Therapeutics, Inc. (ESPR) To Provide Fourth Quarter And Full Year ETC-1002 Program Updates And Financial Results 2/27/2015
Biotie Financial Statement Release 2014 2/27/2015
Neovacs SA: Financial Results For 2014 2/27/2015
IGI Laboratories, Inc. To Hold Conference Call For 4th Quarter 2014 Results 2/27/2015
PTC Therapeutics (PTCT) Reports Fourth Quarter And 2014 Full Year Financial Results And Provides Corporate Update 2/27/2015
Isis Pharmaceuticals, Inc. (ISIS) Reports Financial Results And Highlights For 2014 2/27/2015
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2014 2/27/2015
Synta Pharmaceuticals (SNTA) To Host Conference Call And Webcast Of Fourth Quarter And Year-End 2014 Financial Results On March 12, 2015 2/27/2015
Cerus Corporation (CERS) Reports Fourth Quarter And Year-End 2014 Results 2/27/2015
Concert Pharmaceuticals, Inc. (CNCE) Reports Year End 2014 Financial Results 2/27/2015
Trimel Pharmaceuticals (TRL.TO) To Report Financial Results For 2014 And Host Conference Call To Update Investors 2/27/2015
1st Dental Laboratories (FDT.L) Reports 2014 Fourth Quarter And Full Year Financial Results 2/27/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Year-end Report 2014 2/27/2015
Medivir AB (MVRBF): Financial Statement, January – December 2014 2/27/2015
Nanobiotix 2014 Q4 And Annual Revenues 2/27/2015
Solazyme, Inc. Reports Fourth Quarter And Full Year 2014 Results 2/27/2015
Aegerion (AEGR) Announces Fourth Quarter And Full Year 2014 Financial Results 2/27/2015
Cempra Pharmaceuticals, Inc. (CEMP) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 2/26/2015
Ardelyx Inc. (ARDX) Reports Fourth Quarter and Full Year 2014 Financial Results 2/26/2015
BioMarin (BMRN) Announces Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
China Cord Blood Corporation Reports Financial Results For The Third Quarter And First Nine Months Of Fiscal 2015 2/26/2015
Cellular Dynamics To Host Fourth Quarter And Full Year 2014 Financial Results Webcast And Call 2/26/2015
Radient Technologies Inc. Releases Third Quarter Results And Appoints New Interim CFO 2/26/2015
BioReference Laboratories, Inc. (BRLI) Announces Earnings Date For First Quarter Fiscal Year 2015 2/26/2015
CTI BioPharma To Report Fourth Quarter And Full Year 2014 Financial Results On March 12, 2015 2/26/2015
Receptos (RCPT) To Hold Fourth Quarter And Year End 2014 Financial Results Conference Call 2/26/2015
Harvard Bioscience Inc. (HBIO) Fourth Quarter 2014 Non-GAAP EPS Increases 100% Versus Fourth Quarter 2013 On Record Quarterly Revenues Of $30.4 Million 2/26/2015
IMRIS To Hold Fourth Quarter And Annual 2014 Financial Results Conference Call 2/26/2015
ProQR Therapeutics B.V. (PRQR) Announces Results For The Fourth Quarter And Full Year 2014 2/26/2015
RedHill Biopharma Ltd. (RDHL) Reports 2014 Fourth Quarter And Year-End Financial Results 2/26/2015
QLT Inc. (QLTI) Announces Fourth Quarter And Year End 2014 Results 2/26/2015
Akorn, Inc. (AKN) Reports Preliminary Fourth Quarter And Full Year 2014 Results 2/26/2015
Apollo Medical Holdings Reports Third Quarter Fiscal Year 2015 Financial Results 2/26/2015
AxoGen, Inc. (AXGN) To Report Fourth Quarter And Full Year Financial Results On March 5, 2015 2/26/2015
Senomyx, Inc. (SNMX) Announces Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
SciClone Pharmaceuticals, Inc. (SCLN) To Report Financial Results For The Fourth Quarter And Full Year 2014 On March 11th 2/26/2015
Marina Biotech, Inc. (MRNA) Provides 2014 Year-End Financials And Update 2/26/2015
Thermo Fisher Scientific (TMO) Declares Quarterly Dividend 2/26/2015
Geron Corporation (GERN) Announces Conference Call To Discuss Fourth Quarter And Annual 2014 Financial Results And Recent Events 2/26/2015
Dyadic International, Inc. To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2/26/2015
Clovis Oncology (CLVS) Announces 2014 Operating Results 2/26/2015
bluebird bio (BLUE) Reports Fourth Quarter And Full Year 2014 Financial Results And Recent Operational Progress 2/26/2015
Anika Therapeutics (ANIK) Reports Fourth-Quarter And Full-Year 2014 Financial Results 2/26/2015
Sarepta (SRPT) Announces Fourth Quarter And Full-Year 2014 Financial Results And Recent Corporate Developments 2/26/2015
Agenus (AGEN) Reports Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
Evogene Ltd. (EVGN) Reports Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
Medivation, Inc. (MDVN) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 2/26/2015
Navidea Biopharmaceuticals (NAVB) To Announce Fourth Quarter And Year-End 2014 Financial Results On March 5, 2015 2/26/2015
Circassia Pharmaceuticals Plc Preliminary Results For The Year Ended 31 December 2014 2/26/2015
Ablynx (ABLYF) Announces 2014 Full Year Results 2/26/2015
Histogenics Corporation Announces Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
Vical Incorporated (VICL) Reports Fourth Quarter 2014 Financial Results And Progress In Key Development Programs 2/26/2015
Merrimack Pharmaceuticals Inc. (MACK) Reports Fourth Quarter 2014 Financial Results 2/26/2015
NewLink Genetics Provides Operational Update And Reports Fourth Quarter And Year End 2014 Financial Results 2/26/2015
ChemoCentryx, Inc. (CCXI) To Hold Fourth Quarter 2014 Financial Results Conference Call On Thursday, March 12, 2015 2/26/2015
XOMA (US) LLC (XOMA) To Announce Fourth Quarter And Full Year 2014 Financial Results And Host Webcast On March 11 2/26/2015
MedAssets, Inc. To Present At The Barclays Global Healthcare Conference On March 11th 2/26/2015
Exelixis, Inc. (EXEL) Announces Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 2/25/2015
Portola Pharmaceuticals, Inc. To Announce Fourth Quarter And Year End 2014 Financial Results And Host Conference Call On Monday, March 2 2/25/2015
Curis, Inc. (CRIS) Reports Fourth Quarter And Year-End 2014 Financial Results 2/25/2015
MannKind Corporation (MNKD) Reports 2014 Fourth Quarter And Full Year Financial Results 2/25/2015
Codexis, Inc. (CDXS) To Hold 2014 Fourth Quarter And Full Year Conference Call On March 3 2/25/2015
Amicus Therapeutics, Inc. (FOLD) To Announce Full-Year 2014 Financial Results On March 3, 2015 2/25/2015
Macrocure (MCUR) Announces Fourth Quarter And Full Year 2014 Financial Results Date And Conference Call 2/25/2015
Alder Biopharmaceuticals Inc. To Host Conference Call To Discuss Fourth Quarter And Full Year 2014 Financial And Operating Results 2/25/2015
Parnell Pharmaceuticals Holdings Announces Financial Results For The Six-Month Period Ended December 31, 2014 2/25/2015
Tandem Diabetes Care Reports Fourth Quarter and Full Year 2014 Financial Results 2/25/2015
Jazz Pharmaceuticals (JAZZ) Announces Full Year And Fourth Quarter 2014 Financial Results 2/25/2015
Nektar Therapeutics (CA) (NKTR) Reports Fourth Quarter and Year-End 2014 Financial Results 2/25/2015
HEALTHSOUTH Reports Results For Fourth Quarter And Full Year 2014 2/25/2015
Orexigen Therapeutics, Inc. (OREX) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2014 2/25/2015